Le Registre des lobbyistes
Objets | Détails | Catégories |
---|---|---|
Santé,
Sciences et technologies
|
Communicating with government officials about data exclusivity, more specifically as it relates to the use of natural health products in biopharmaceutical preparations.
|
Politique ou Programme
|
Santé,
Travail
|
Communicating with government officials about federal healthcare benefits, including those delivered by members of the Federal Healthcare Partnership ("FHP"), such as the Department of National Defence, the Department of Indigenous Services, the Royal Canadian Mounted Police and the Department of Veterans Affairs.
|
Politique ou Programme
|
Santé
|
Communicating with government officials about guidance, policies and documents issued by the Office of Patented Medicines and Liaison ("OPML") within the Office of Submissions and Intellectual Property, Therapeutic Products Directorate ("TPD").
|
Politique ou Programme
|
Santé,
Sciences et technologies
|
Communicating with government officials about initiatives, partnerships research and programs by the Canadian Institutes of Health Research ("CIHR").
|
Politique ou Programme
|
Commerce international,
Propriété intellectuelle,
Santé
|
Communicating with government officials about international trade matters, including intellectual property provisions under the Canada-European Union Comprehensive Economic and Trade Agreement (“CETA”) and the Trans-Pacific Partnership (“TPP”).
|
Proposition législative, Projet de loi ou résolution
|
Propriété intellectuelle,
Santé
|
Communicating with government officials about regulations related to patented medicines, including the Patented Medicines (Notice of Compliance) Regulations (SOR/93-133) under the Patent Act.
|
Règlement
|
Environnement,
Santé
|
Communicating with government officials about regulations related to safe and environmentally-responsible disposal of biopharmaceutical compounds, including the Food and Drug Regulations (C.R.C., c. 870) under the Food and Drugs Act.
|
Politique ou Programme
|
Propriété intellectuelle,
Santé
|
Communicating with government officials about regulations, guidelines reviews, references and reporting requirements issued by and/or related to the Patented Medicine Prices Review Board ("PMPRB").
|
Règlement
|
Commerce international,
Santé,
Sciences et technologies
|
Communicating with government officials about the Food and Drugs Act, more specifically about (i) export restrictions, (ii) cross-border trade of biopharmaceuticals, (iii) approval, regulation and life-cycle management of therapeutic products and (iv) data protection.
|
Proposition législative, Projet de loi ou résolution
|
Propriété intellectuelle,
Santé
|
Communicating with government officials about the Patent Act, more specifically about the regulation of intellectual property for therapeutic products.
|
Proposition législative, Projet de loi ou résolution
|
Impôts et finances,
Santé,
Sciences et technologies
|
Communicating with government officials about the Scientific Research and Experimental Development ("SR&ED") Tax Incentive Program, more specifically about investments in biopharmaceutical and health technology innovation.
|
Subvention, Contribution ou autre avantage financier
|
Santé
|
Communicating with government officials about the development of a national pharmacare program with the goal of (i) improving patient well-being and health outcomes and (ii) improving access to effective treatments for patients.
|
Politique ou Programme
|
Santé
|
Communicating with government officials about the modernization and improvement of Health Canada's "Progressive Licensing Framework".
|
Politique ou Programme
|
Santé
|
Communicating with government officials, in general, about policies and programs related to improving access for Canadian patients to effective treatments for common mental health, addiction and neuro-degenerative conditions.
|
Politique ou Programme
|
Santé
|
Communicating with government officials, in general, about programs, reports, reviews and policies issued by or related to Canada's Drug Agency (formerly known as the Canadian Agency for Drugs and Technologies in Health).
|
Politique ou Programme
|
Impôts et finances,
Santé
|
Communicating with government officials—including through the pan-Canadian Pharmaceutical Alliance (formerly known as the Pan-Canadian Pricing Alliance)—about drug pricing and reimbursement.
|
Politique ou Programme
|
Objets | Détails | Catégories |
---|---|---|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Canadian Institutes of Health (CIHR) initiatives, such as the Drug Safety and Effectiveness Network (DSEN), and various research programs, particularly as they relate to public/private research and development partnerships
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Data exclusivity as it relates to the use of Natural Health Products in biopharmaceutical preparations.
|
Politique ou Programme,
Règlement
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Development of a Canadian National Pharmacare Program with a primary focus on improving patient well-being and health outcomes access to effective treatments for patients.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Environment and Climate Change Canada and/or Food and Drugs Act regulations as they relate to the safe and environmentally responsible disposal of biopharmaceutical compounds.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Existing or proposed policies and programs related to improving access to effective treatments for common mental health, addiction and neuro-degenerative for Canadian patients.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Federal Health Partnership with respect to the co-ordination of federal health benefit plan policies and programs.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Federal policies related to, and interactions with, the Canadian Agency for Drugs and Technologies in Health (CADTH) particularly pertaining to its Common Drug Review (CDR), Health Technology Assessment (HTA), and the Canadian Optimal Medication Prescribing & Utilization Service (COMPUS) units.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Food and Drug Regulations as it relates to data protection (Section C.08.004) and the regulation and protection of biopharmaceutical products
|
Règlement
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Food and Drugs Act & regulations as they relate to export restrictions and cross border trade of biopharmaceuticals.
|
Proposition législative, Projet de loi ou résolution,
Règlement
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
|
Proposition législative, Projet de loi ou résolution
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Health Canada (including the Office of Patented Medicines and Liason (OPML)) policies and regulations with regards to therapeutic products
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Health benefits programs of Immigration, Refugees and Citizenship Canada, Correctional Services of Canada, Health Canada (NIHB), the Department of National Defence, the Royal Canadian Mounted Police, and Veterans Affairs Canada with respect to decisions and policies which impact the reimbursement of biopharmaceutical therapeutic products for plan beneficiaries.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
International Trade Canada's "Invest in Canada" policies and programs with respect to investment, business development and innovation in the life sciences industry sector.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
International Trade policy initiatives related to implementing / strengthening the Canada-Europe Trade Agreement (CETA)and the Trans-Pacific Partnership (TPP), including recognition of patent term restoration within Canada's intellectual property protection regime
|
Politique ou Programme,
Proposition législative, Projet de loi ou résolution
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Mobilizing Science and Technology to Canada's Advantage, the federal science and technology strategy, with respect to the health and related life sciences and technologies priority area
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Modernization of Health Canada's Progressive Licensing framework as it relates to the review and approval of biopharmaceutical products
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
National Pharmaceutical Strategy (NPS) as it relates to the federal government's involvement in the federal/provincial/territorial governments' access to medicines framework
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Pan-Canadian Pricing Alliance as it relates to drug pricing and reimbursement.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Patent Act as it relates to the regulation of intellectual property for therapeutic products
|
Politique ou Programme,
Règlement
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Patent Act with respect to Patented Medecines (Notice of Compliance (NOC)) Regulations and to Patented Medicines Regulations.
|
Règlement
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Patented Medicines Prices Review Board (PMPRB) Regulations as they relate to reporting requirements and pricing guidelines as well as reference pricing and the modernization of PMPRB regulatory framework.
|
Règlement
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Scientific Research and Experimental Development (SR&ED) Tax Incentive Program as it relates to investment in biopharmaceutical and related health technology innovation.
|
Politique ou Programme
|
Techniques de communication déjà utilisées ou qui seront utilisées au cours de l'engagement :